Search Results - "O’Toole, R.V"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Fixation of displaced femoral neck fractures in young adults: Fixed-angle devices or Pauwel screws? by Hoshino, C.M, Christian, M.W, O’Toole, R.V, Manson, T.T

    Published in Injury (01-08-2016)
    “…Abstract Background We sought to compare the incidence of complications after fixation of displaced femoral neck fractures in young adults treated with…”
    Get full text
    Journal Article
  2. 2

    Splenectomy as Part of Cytoreductive Surgery for Ovarian Carcinoma by Nicklin, J.L., Copeland, L.J., O'Toole, R.V., Lewandowski, G.S., Vaccarello, L., Havenar, L.P.

    Published in Gynecologic oncology (01-08-1995)
    “…Splenectomy is sometimes necessary to achieve optimal cytoreduction or manage iatrogenic injury in the surgical management of epithelial ovarian cancer (EOC)…”
    Get full text
    Journal Article
  3. 3

    Immunohistochemical evaluation of human placental implantation: an initial study by Tuttle, S E, O'Toole, R V, O'Shaughnessy, R W, Zuspan, F P

    “…Immunohistochemical staining for human chorionic gonadotropin and factor VIII-related antigen with the avidin-biotin complex immunoperoxidase technique was…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Phase II trial of vinblastine in previously treated patients with ovarian cancer: a Southwest Oncology Group Study by Surwit, E A, Alberts, D S, O'Toole, R V, Graham, V, Hannigan, E V, Stephens, R L, Boutselis, J G

    Published in Gynecologic oncology (01-06-1987)
    “…Sixty-eight patients with relapsing, epithelial type ovarian carcinoma were entered into a Phase II study of vinblastine. Vinblastine was administered as a…”
    Get more information
    Journal Article
  6. 6

    Phase II trial of vinblastine in previously treated patients with ovarian cancer: a Southwest Oncology Group Study by Surwit, E A, Alberts, D S, O'Toole, R V, Graham, V, Hannigan, E V, Stephens, R L, Boutselis, J G

    Published in Gynecologic oncology (01-09-1987)
    “…Sixty-eight patients with relapsing, epithelial type ovarian carcinoma were entered into a Phase II study of vinblastine. Vinblastine was administered as a…”
    Get more information
    Journal Article